{site_meta && site_meta.display_name} Logo

Reportable

Cut through the daily deluge of information from news, social media and scientific literature to better communicate to your audiences, monitor and measure your business reputation and keep a close eye on your competition.

RSS Feed for Reportable

Lifordi Immunotherapeutics to Present New Preclinical Data on Antibody Drug Conjugate LFD-200 Demonstrating Selective and Sustained Delivery of Glucocorticoid Payload to Immune Tissues Without Evidence of Toxicity

October 10, 2025 — BURLINGTON, MA – October 10, 2025 -- Lifordi Immunotherapeutics, Inc. , a biotech company developing antibody drug conjugates (ADCs) for the treatment of autoimmune and inflammatory disorders, will present additional preclinical data on its lead candidate LFD-200, an ADC delivering a potent glucocorticoid (GC) directly to immune cells.

PR Club of New England Expands for 2025-2026 Season

October 1, 2025 — Boston, MA: October, 1, 2025 – The PR Club of New England, the region’s leading communications trade organization, today announced its new and expanded board of directors and strategic vision for the 2025-2026 term. Led by returning president Kaitlynn Cooney, the PR Club is committed to honoring its 77-year historic legacy, while setting the organization up for long-term success through educational programming, professional networking events, and membership growth.

Tevard Biosciences Presents Data Showing Compelling Full-Length Protein Rescue with tRNA-based Treatment for Duchenne Muscular Dystrophy and Dilated Cardiomyopathy at the 2025 FEBS Special Meeting

September 29, 2025 — Boston, MA - September 29, 2025 - Tevard Biosciences, Inc. , a privately held biotechnology company pioneering tRNA-based therapies to cure a broad range of genetic diseases, today announced the presentation of new preclinical data showing potent restoration of full-length functional proteins in models of Duchenne muscular dystrophy (DMD) and dilated cardiomyopathy caused by titin truncations (DCM-TTNtv).

UGI to Begin Upgrades in Camp Hill Next Week

September 26, 2025 — FOR IMMEDIATE RELEASE Release Date: September 26, 2025 UGI Utilities, Inc. is scheduled to begin a natural gas main replacement project in Camp Hill on Wednesday, October 1.

Kotobuki Seating International Brings Comfort and Accessibility to the Revitalized Delacorte Theater in Central Park

September 25, 2025 — Kotobuki Seating International, the international leader in public seating design and manufacturing, is proud to announce its role in the full-scale revitalization of The Delacorte Theater in Central Park, home to The Public Theater’s renowned Free Shakespeare in the Park. In close collaboration with Ennead Architects, Fisher Dachs Associates Theater Planning and Design and Kotobuki designed and produced 1,864 new seats that merge ergonomic performance, outdoor durability, and inclusive design—setting a new benchmark for spectator comfort in the theater’s 63-year history.

Mitch Gould and Nutritional Products International: Four Decades of Retail Success Across America’s Largest Chains

September 25, 2025 — September 25th, 2025- Boca Raton, Florida- Mitch Gould, founder and CEO of Nutritional Products International (NPI), has built a career spanning more than 30 years at the crossroads of retail and brand development. His work has taken him into the boardrooms of virtually every major retailer in the United States and has included collaborations with some of the biggest names in consumer products, beverages, sports nutrition, and health and wellness.

Altss Grows to 9,000 Family Offices—the Largest FO Database—and Readies Full LP Intelligence

September 24, 2025 — September 24th, 2025- Miami, Florida- Altss announced a major expansion of its allocator intelligence platform, increasing verified family-office coverage to 9,000—the largest family-office database globally. The update is designed for general partners (GPs) and investor-relations (IR) teams that need current, decision-grade context on who allocates, why, and when.